Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiuwei Xifeng Granules in Pediatric Tic Disorders
CTR20170602Phase 4Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jun 2017
- Countries
- 1
01
Overview
A Phase 4 trial of Jiuwei Xifeng Granules in tic disorder, Provisional Tic Disorder (PTD), chronic tic disorder, Tourette syndrome (TS), attention deficit hyperactivity disorder (ADHD), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jun 2017; status: active.
02
Drugs
Jiuwei Xifeng Granules
03
Conditions
tic disorderProvisional Tic Disorder (PTD)chronic tic disorderTourette syndrome (TS)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on CTR20170602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170602.